Concord Medical Services Holdings Ltd (CCM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 60M 120M 180M FY11: 71.5M FY12: 106.3M FY13: 162M FY14: 97.8M FY15: 95.2M FY16: 65.5M FY17: 50.9M FY18: 27.8M FY19: 28.5M FY20: 34.2M FY21: 76.2M FY22: 68.4M FY23: 75.7M FY24: 52.6M FY25: 65.9M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

-25M 0 25M 50M 75M FY11: 46.2M FY12: 52.2M FY13: 65M FY14: 53.6M FY15: 40.6M FY16: 24.3M FY17: 15.1M FY18: 2.9M FY19: -2.3M FY20: 2M FY21: -8.9M FY22: -22.1M FY23: -10.8M FY24: -10.8M FY25: 3.7M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-90M -60M -30M 0 30M 60M 90M FY11: -25.6M FY12: 33.2M FY13: 29.9M FY14: 29.6M FY15: -887K FY16: -24.3M FY17: -32.6M FY18: -43.5M FY19: -62.8M FY20: -48.4M FY21: -71.9M FY22: -76.1M FY23: -65.2M FY24: -72.9M FY25: -37.4M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-75M -50M -25M 0 25M 50M 75M FY11: -34.2M FY12: 21M FY13: 14.2M FY14: 20.1M FY15: -12.1M FY16: -37.7M FY17: -43.7M FY18: -34.2M FY19: -44.1M FY20: -47.5M FY21: -42.6M FY22: -71M FY23: -41.9M FY24: -42.2M FY25: -13.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 35M 70M 105M FY11: 25.3M FY12: 54.1M FY13: 97M FY14: 44.3M FY15: 54.5M FY16: 41.3M FY17: 35.8M FY18: 24.9M FY19: 30.8M FY20: 32.2M FY21: 85.1M FY22: 90.5M FY23: 86.5M FY24: 63.4M FY25: 62.2M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

-60M -30M 0 30M 60M 90M FY11: 21.8M FY12: 41.7M FY13: 42.8M FY14: 79M FY15: -27M FY16: -11.2M FY17: 4.1M FY18: -5.6M FY19: -28.1M FY20: -35.2M FY21: -56.4M FY22: -31.4M FY23: -38.9M FY24: -54.5M FY25: -28.9M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-105M -70M -35M 0 35M 70M 105M FY11: 18.9M FY12: 31.1M FY13: 30.5M FY14: 70.7M FY15: -34.4M FY16: -22.6M FY17: -9.9M FY18: -29.7M FY19: -61.5M FY20: -61M FY21: -100.2M FY22: -63.7M FY23: -54.9M FY24: -75.1M FY25: -36.9M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 50M 100M 150M FY12: 138.2M FY13: 135.1M FY14: 135.2M FY15: 134.5M FY16: 130.6M FY20: 131.1M FY21: 131.1M FY22: 131.1M FY23: 131.1M FY24: 131.1M FY25: 131.1M FY12 FY13 FY14 FY15 FY16 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.